help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gadot, M.
Right arrow Articles by Gross, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gadot, M.
Right arrow Articles by Gross, D. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes

Endocrinology, Vol 136, 4218-4223, Copyright © 1995 by Endocrine Society

ARTICLES

Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell

M Gadot, Y Ariav, E Cerasi, N Kaiser and DJ Gross
Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem, Israel.

We have recently shown that the diabetic syndrome in Psammomys obesus is characterized by severe depletion of islet immunoreactive insulin (IRI) stores together with a marked increase in the islet proinsulin to insulin ratio. In the present in vitro studies, we show marked enhancement of proinsulin biosynthesis in islets from diabetic P. obesus (approximately 8-fold compared to nondiabetic islets). Proinsulin to insulin conversion and insulin degradation do not differ significantly between diabetic and nondiabetic islets. The rate of IRI secretion at a stimulatory concentration of glucose (16.7 mM) is comparable in diabetic and nondiabetic animals, but at a nonstimulatory glucose concentration (0 mM), islets obtained from diabetic animals show significant IRI release. beta-Cells from diabetic P. obesus also exhibited increased secretion of newly synthesized proinsulin and conversion intermediates under stimulatory conditions. Moreover, a novel secretory compartment, highly enriched in newly synthesized C peptide, characterized the beta-cells of diabetic animals. Our data suggest that the marked insulin depletion observed in diabetic islets is probably due to a hyperglycemia-driven increase in secretory demand that is not met by the enhanced biosynthetic capacity of these islets. This leads to relative enrichment of the depleted diabetic islets with immature secretory granules of a higher proinsulin content.


This article has been cited by other articles:


Home page
 J EndocrinolHome page
A. Borjesson and C. Carlsson
Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1{beta}
J. Endocrinol., February 1, 2007; 192(2): 381 - 387.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Kaiser, R. Nesher, M. Y. Donath, M. Fraenkel, V. Behar, C. Magnan, A. Ktorza, E. Cerasi, and G. Leibowitz
Psammomys Obesus, a Model for Environment-Gene Interactions in Type 2 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S137 - S144.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
G Uckaya, P Delagrange, A Chavanieu, G Grassy, M-F Berthault, A Ktorza, E Cerasi, G Leibowitz, and N Kaiser
Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue
J. Endocrinol., March 1, 2005; 184(3): 505 - 513.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Kaiser, M. Yuli, G. Uckaya, A. I. Oprescu, M.-F. Berthault, C. Kargar, M. Y. Donath, E. Cerasi, and A. Ktorza
Dynamic Changes in {beta}-Cell Mass and Pancreatic Insulin During the Evolution of Nutrition-Dependent Diabetes in Psammomys obesus: Impact of Glycemic Control
Diabetes, January 1, 2005; 54(1): 138 - 145.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Leibowitz, G. Uckaya, A. I. Oprescu, E. Cerasi, D. J. Gross, and N. Kaiser
Glucose-Regulated Proinsulin Gene Expression Is Required for Adequate Insulin Production during Chronic Glucose Exposure
Endocrinology, September 1, 2002; 143(9): 3214 - 3220.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Nesher, N. Warwar, A. Khan, S. Efendic, E. Cerasi, and N. Kaiser
Defective Stimulus-Secretion Coupling in Islets of Psammomys obesus, an Animal Model for Type 2 Diabetes
Diabetes, February 1, 2001; 50(2): 308 - 314.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Hostens, Z. Ling, C. Van Schravendijk, and D. Pipeleers
Prolonged Exposure of Human {beta}-Cells to High Glucose Increases Their Release of Proinsulin during Acute Stimulation with Glucose or Arginine
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1386 - 1390.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. L. Prigeon, S. E. Kahn, and D. Porte Jr.
Effect of Troglitazone on B Cell Function, Insulin Sensitivity, and Glycemic Control in Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 819 - 823.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society